Universal Ibogaine Inc. announced a non-brokered private placement of up to 23,333,333 common shares at a price of CAD 0.015 per share, for proceeds of up to $349,999.995 on April 22, 2024. The completion of the offering is subject to approval by the TSX Venture Exchange. All shares issued under the offering will be subject to a four-month hold period as required by the rules of the TSXV and Canadian Securities Laws, as well as any required hold periods under US Securities Laws for US resident purchasers.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | 0.00% | 0.00% | +200.00% |
Apr. 22 | Universal Ibogaine Inc. Elects Ken Cranwill as Board of Director | CI |
Apr. 22 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.35 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+200.00% | 3.21M | |
+17.91% | 85.14B | |
-27.67% | 72.06B | |
+2.75% | 27.07B | |
-9.39% | 17.43B | |
-1.96% | 16.98B | |
+3.95% | 16.02B | |
+8.41% | 13.87B | |
+70.13% | 13.06B | |
+73.04% | 12.79B |
- Stock Market
- Equities
- IBO Stock
- News Universal Ibogaine Inc.
- Universal Ibogaine Inc. announced that it expects to receive CAD 0.35 million in funding